의약품 업계용 콜드체인 물류 시장(2026-2030년)

The global cold chain logistics market for pharmaceuticals industry is forecasted to grow by USD 16759.8 mn during 2025-2030, accelerating at a CAGR of 10.4% during the forecast period. The report on the global cold chain logistics market for pharmaceuticals industry provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by proliferation of biologics and advanced therapy medicinal products, mainstream adoption of direct-to-patient (dtp) and decentralized clinical trial models, regionalization of supply chains and emergence of new global trade corridors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cold chain logistics market for pharmaceuticals industry is segmented as below:

By Product

• Vaccines
• Biopharmaceuticals
• Clinical trial materials

By Service

• Warehousing and VAS
• Transportation

By Delivery Mode

• Refrigerated
• Frozen
• Cryogenic
• Controlled room temperature

Geography

• APAC
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The Netherlands
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • South Africa
  • UAE
  • Egypt
• Rest of World (ROW)

This study identifies the expansion of ultra-cold and cryogenic infrastructure for advanced therapeutics as one of the prime reasons driving the global cold chain logistics market for pharmaceuticals industry growth during the next few years. Also, implementation of autonomous warehouse automation and robotic thermal management and dominance of ai-driven demand forecasting and dynamic inventory optimization will lead to sizable demand in the market.

The report on the global cold chain logistics market for pharmaceuticals industry covers the following areas:

• Global cold chain logistics market for pharmaceuticals industry sizing
• Global cold chain logistics market for pharmaceuticals industry forecast
• Global cold chain logistics market for pharmaceuticals industry industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cold chain logistics market for pharmaceuticals industry vendors that include Agility Global PLC, Air Canada, Burris Logistics Co., Cold Chain Technologies LLC, Coldman Logistics Pvt. Ltd., Deutsche Post AG, DSV AS, FedEx Corp., Helapet ltd., Kuehne Nagel Management AG, Lineage Inc., Nichirei Corp., PCI Pharma Services, SF Express Co. Ltd., Singhania Logistics Pvt. Ltd., Snowman Logistics Ltd., Uber Technologies Inc., United Parcel Service Inc., XPO Inc.. Also, the global cold chain logistics market for pharmaceuticals industry analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Market Segmentation by Delivery Mode
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cold Chain Logistics Market For Pharmaceuticals Industry 2020 - 2024
  • Historic Market Size - Data Table on Global Cold Chain Logistics Market For Pharmaceuticals Industry 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Service segment analysis 2020 - 2024
  • Historic Market Size - Service Segment 2020 - 2024 ($ million)
• 5.4 Delivery Mode segment analysis 2020 - 2024
  • Historic Market Size - Delivery Mode Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in global cold chain logistics market for pharmaceuticals industry

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Vaccines - Market size and forecast 2025-2030
• 8.4 Biopharmaceuticals - Market size and forecast 2025-2030
• 8.5 Clinical trial materials - Market size and forecast 2025-2030
• 8.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Service

• 9.1 Market segments
• 9.2 Comparison by Service
• 9.3 Warehousing and VAS - Market size and forecast 2025-2030
• 9.4 Transportation - Market size and forecast 2025-2030
• 9.5 Market opportunity by Service
  • Market opportunity by Service ($ million)

10 Market Segmentation by Delivery Mode

• 10.1 Market segments
• 10.2 Comparison by Delivery Mode
• 10.3 Refrigerated - Market size and forecast 2025-2030
• 10.4 Frozen - Market size and forecast 2025-2030
• 10.5 Cryogenic - Market size and forecast 2025-2030
• 10.6 Controlled room temperature - Market size and forecast 2025-2030
• 10.7 Market opportunity by Delivery Mode
  • Market opportunity by Delivery Mode ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 APAC - Market size and forecast 2025-2030
  • 12.3.1 China - Market size and forecast 2025-2030
  • 12.3.2 India - Market size and forecast 2025-2030
  • 12.3.3 Japan - Market size and forecast 2025-2030
  • 12.3.4 South Korea - Market size and forecast 2025-2030
  • 12.3.5 Australia - Market size and forecast 2025-2030
  • 12.3.6 Indonesia - Market size and forecast 2025-2030
• 12.4 North America - Market size and forecast 2025-2030
  • 12.4.1 US - Market size and forecast 2025-2030
  • 12.4.2 Canada - Market size and forecast 2025-2030
  • 12.4.3 Mexico - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 France - Market size and forecast 2025-2030
  • 12.5.3 UK - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 South Africa - Market size and forecast 2025-2030
  • 12.7.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.3 UAE - Market size and forecast 2025-2030
  • 12.7.4 Egypt - Market size and forecast 2025-2030
  • 12.7.5 Israel - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Proliferation of biologics and advanced therapy medicinal products
  • Mainstream adoption of direct-to-patient (DtP) and decentralized clinical trial models
  • Regionalization of supply chains and emergence of new global trade corridors
• 13.2 Market challenges
  • Prohibitive operational costs and complexity of modern aseptic infrastructure
  • Fragmented regulatory landscapes and compliance cliff
  • Technological friction and scalability of IoT-enabled monitoring systems
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of ultra-cold and cryogenic infrastructure for advanced therapeutics
  • Implementation of autonomous warehouse automation and robotic thermal management
  • Dominance of AI-driven demand forecasting and dynamic inventory optimization

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agility Global PLC
  • Agility Global PLC - Overview
  • Agility Global PLC - Business segments
  • Agility Global PLC - Key offerings
  • Agility Global PLC - Segment focus
  • SWOT
• 15.5 Air Canada
  • Air Canada - Overview
  • Air Canada - Business segments
  • Air Canada - Key offerings
  • Air Canada - Segment focus
  • SWOT
• 15.6 Burris Logistics Co.
  • Burris Logistics Co. - Overview
  • Burris Logistics Co. - Product / Service
  • Burris Logistics Co. - Key offerings
  • SWOT
• 15.7 Cold Chain Technologies LLC
  • Cold Chain Technologies LLC - Overview
  • Cold Chain Technologies LLC - Product / Service
  • Cold Chain Technologies LLC - Key offerings
  • SWOT
• 15.8 Deutsche Post AG
  • Deutsche Post AG - Overview
  • Deutsche Post AG - Business segments
  • Deutsche Post AG - Key news
  • Deutsche Post AG - Key offerings
  • Deutsche Post AG - Segment focus
  • SWOT
• 15.9 DSV AS
  • DSV AS - Overview
  • DSV AS - Business segments
  • DSV AS - Key offerings
  • DSV AS - Segment focus
  • SWOT
• 15.10 FedEx Corp.
  • FedEx Corp. - Overview
  • FedEx Corp. - Business segments
  • FedEx Corp. - Key news
  • FedEx Corp. - Key offerings
  • FedEx Corp. - Segment focus
  • SWOT
• 15.11 Kuehne Nagel Management AG
  • Kuehne Nagel Management AG - Overview
  • Kuehne Nagel Management AG - Business segments
  • Kuehne Nagel Management AG - Key news
  • Kuehne Nagel Management AG - Key offerings
  • Kuehne Nagel Management AG - Segment focus
  • SWOT
• 15.12 Lineage Inc.
  • Lineage Inc. - Overview
  • Lineage Inc. - Product / Service
  • Lineage Inc. - Key offerings
  • SWOT
• 15.13 Nichirei Corp.
  • Nichirei Corp. - Overview
  • Nichirei Corp. - Business segments
  • Nichirei Corp. - Key offerings
  • Nichirei Corp. - Segment focus
  • SWOT
• 15.14 PCI Pharma Services
  • PCI Pharma Services - Overview
  • PCI Pharma Services - Product / Service
  • PCI Pharma Services - Key offerings
  • SWOT
• 15.15 SF Express Co. Ltd.
  • SF Express Co. Ltd. - Overview
  • SF Express Co. Ltd. - Business segments
  • SF Express Co. Ltd. - Key offerings
  • SF Express Co. Ltd. - Segment focus
  • SWOT
• 15.16 Uber Technologies Inc.
  • Uber Technologies Inc. - Overview
  • Uber Technologies Inc. - Business segments
  • Uber Technologies Inc. - Key offerings
  • Uber Technologies Inc. - Segment focus
  • SWOT
• 15.17 United Parcel Service Inc.
  • United Parcel Service Inc. - Overview
  • United Parcel Service Inc. - Business segments
  • United Parcel Service Inc. - Key news
  • United Parcel Service Inc. - Key offerings
  • United Parcel Service Inc. - Segment focus
  • SWOT
• 15.18 XPO Inc.
  • XPO Inc. - Overview
  • XPO Inc. - Business segments
  • XPO Inc. - Key news
  • XPO Inc. - Key offerings
  • XPO Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations